USFDA gives nod to Strides Pharma for Colchicine tablets

According to IQVIA MAT January 2022 data, the US market for colchicine tablets USP, 0.6 mg is stood at around USD 85 million.

272
USFDA Approval
USFDA Approval

Last Updated on October 10, 2024 by The Health Master

New Delhi: Drug firm Strides Pharma Science on Friday said its subsidiary has received approval from the US health regulator to sell colchicine tablets, used for the treatment and prevention of gout, in the American market.

Singapore-based Strides Pharma Global Pte, a step down wholly-owned subsidiary of the company, has received approval from the United States Food & Drug Administration (USFDA) to market the product, Strides Pharma Science said in a statement.

The company’s product, which reduces inflammation and other symptoms of gout, is therapeutically equivalent to Takeda Pharmaceuticals’ Colcrys tablets.

According to IQVIA MAT January 2022 data, the US market for colchicine tablets USP, 0.6 mg is stood at around USD 85 million.

Strides said the product will be manufactured at the company’s facility at Bengaluru and will be marketed by Strides Pharma Inc in the US market.

The company has 271 cumulative ANDA filings with USFDA, of which 245 ANDAs have been approved and 26 are pending approval, it added.

USFDA gives nod to Alembic Pharmaceuticals for anti fungal drug

USFDA gives nod to Aleor for Nystatin and Triamcinolone Acetonide Ointment

USFDA approves expanded use of cancer drug Opdivo

USFDA gives nod to Lupin for generic Jublia topical solution

USFDA gives nod to Lupin for Sevelamer Hydrochloride Tablets, 800 mg

USFDA approves this drug for bone marrow cancer treatment

NITI Aayog to release policy on integrative medicine, white paper onmanufacturing Medical Devices

DCGI gives EUA nod to Covovax for 12-17 years age group

Govt joins hands with industry to set up Pharma Park

Mandatory QR codes on APIs: Benefit or burden?

USFDA gives nod to Alembic Pharmaceuticals for anti fungal drug

Govt amends rules to allow import license for Medical Devices: Read

IPC flags safety alert against Blood Pressure drug, Losartan

USFDA gives nod to Aleor for Nystatin and Triamcinolone Acetonide Ointment

ICMR in collaboration with pharma companies to develop Dengue vaccine

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news